These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33636537)

  • 1. Medulloblastoma drugs in development: Current leads, trials and drawbacks.
    Wen J; Hadden MK
    Eur J Med Chem; 2021 Apr; 215():113268. PubMed ID: 33636537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rationale for targeted therapies in medulloblastoma.
    MacDonald TJ; Aguilera D; Castellino RC
    Neuro Oncol; 2014 Jan; 16(1):9-20. PubMed ID: 24305711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
    Liu X; Ding C; Tan W; Zhang A
    Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights into medulloblastoma relapse.
    Peterson K; Turos-Cabal M; Salvador AD; Palomo-Caturla I; Howell AJ; Vieira ME; Greiner SM; Barnoud T; Rodriguez-Blanco J
    Pharmacol Ther; 2024 Aug; 260():108673. PubMed ID: 38857789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
    Genovesi LA; Millar A; Tolson E; Singleton M; Hassall E; Kojic M; Brighi C; Girard E; Andradas C; Kuchibhotla M; Bhuva DD; Endersby R; Gottardo NG; Bernard A; Adolphe C; Olson JM; Taylor MD; Davis MJ; Wainwright BJ
    Genome Med; 2021 Jun; 13(1):103. PubMed ID: 34154646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling pathway and molecular subgroups of medulloblastoma.
    Li KK; Lau KM; Ng HK
    Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.
    Li Y; Song Q; Day BW
    Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
    Packer RJ
    Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.
    Chen SM; Li YY; Tu CH; Salazar N; Tseng YY; Huang SF; Hsieh LL; Lui TN
    PLoS One; 2016; 11(8):e0161299. PubMed ID: 27537345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy.
    Song H; Bhakat R; Kling MJ; Coulter DW; Chaturvedi NK; Ray S; Joshi SS
    Biochem Biophys Res Commun; 2019 Dec; 520(2):250-256. PubMed ID: 31594641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old drugs still work! Oral etoposide in a relapsed medulloblastoma.
    Perez-Somarriba M; Andión M; López-Pino MA; Lavarino C; Madero L; Lassaletta A
    Childs Nerv Syst; 2019 May; 35(5):865-869. PubMed ID: 30707305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma.
    Gordon RE; Zhang L; Peri S; Kuo YM; Du F; Egleston BL; Ng JMY; Andrews AJ; Astsaturov I; Curran T; Yang ZJ
    Clin Cancer Res; 2018 Mar; 24(6):1375-1388. PubMed ID: 29437795
    [No Abstract]   [Full Text] [Related]  

  • 13. SHH inhibitors for the treatment of medulloblastoma.
    Samkari A; White J; Packer R
    Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma.
    Kim J; Dey A; Malhotra A; Liu J; Ahn SI; Sei YJ; Kenney AM; MacDonald TJ; Kim Y
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24205-24212. PubMed ID: 32934143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma.
    Lospinoso Severini L; Ghirga F; Bufalieri F; Quaglio D; Infante P; Di Marcotullio L
    Expert Opin Ther Targets; 2020 Nov; 24(11):1159-1181. PubMed ID: 32990091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.
    Endersby R; Whitehouse J; Pribnow A; Kuchibhotla M; Hii H; Carline B; Gande S; Stripay J; Ancliffe M; Howlett M; Schoep T; George C; Andradas C; Dyer P; Schluck M; Patterson B; Tacheva-Gigorova SK; Cooper MN; Robinson G; Stewart C; Pfister SM; Kool M; Milde T; Gajjar A; Johns T; Wechsler-Reya RJ; Roussel MF; Gottardo NG
    Sci Transl Med; 2021 Jan; 13(577):. PubMed ID: 33472956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma.
    Infante P; Malfanti A; Quaglio D; Balducci S; De Martin S; Bufalieri F; Mastrotto F; Basili I; Garofalo M; Lospinoso Severini L; Mori M; Manni I; Moretti M; Nicoletti C; Piaggio G; Caliceti P; Botta B; Ghirga F; Salmaso S; Di Marcotullio L
    Cancer Lett; 2021 Feb; 499():220-231. PubMed ID: 33249196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.
    Bai RY; Staedtke V; Rudin CM; Bunz F; Riggins GJ
    Neuro Oncol; 2015 Apr; 17(4):545-54. PubMed ID: 25253417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway.
    Chen J; Lv H; Hu J; Ji M; Xue N; Li C; Ma S; Zhou Q; Lin B; Li Y; Yu S; Chen X
    Cancer Lett; 2016 Oct; 381(2):391-403. PubMed ID: 27495899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.